Human Natural Anti-alpha-galactosyl IgG. II. The Specific Recognition of Alpha (1----3)-linked Galactose Residues
Overview
General Medicine
Authors
Affiliations
A natural IgG antibody (anti-Gal) with alpha-galactosyl binding specificity has been found in large amounts (0.5 - 1.0% of serum IgG) in all individuals tested. It has been purified by affinity chromatography on a column of melibiose-Sepharose. In addition to its affinity for normal and pathological senescent human red cells, the antibody readily interacts with rabbit red blood cell (RRBC) glycolipids with alpha-galactosyl terminal residues. Two types (glycosidic linkages of 1----3 vs. 1----4) of rabbit red cells glycolipids with terminal alpha-galactosyl residues were tested for antibody binding. The antibody specifically bound to glycolipids with Gal alpha 1----3 terminal residues, and treatment of these glycolipids with alpha-galactosidase abolished binding. Hemagglutination inhibition studies with oligosaccharides of known structure also showed that the antibody binds specifically to glycoconjugates with an alpha 1----3 terminal galactose residue. Anti-Gal did not bind to a human B-active glycolipid, indicating that fucose-linked alpha 1----2 to the penultimate galactose prevents anti-Gal binding. The anti-Gal specificity for RRBC glycolipids also paralleled that of the alpha-galactosyl-specific Bandeiraea simplicifolia lectin. The possible reasons for the occurrence of this unique antibody in human serum are discussed.
Self-Tumor Antigens in Solid Tumors Turned into Vaccines by α-gal Micelle Immunotherapy.
Galili U Pharmaceutics. 2024; 16(10).
PMID: 39458595 PMC: 11510312. DOI: 10.3390/pharmaceutics16101263.
Cardiac Xenotransplantation: a New Frontier for Advanced Heart Failure.
Montgomery R, Tang W Curr Treat Options Cardiovasc Med. 2024; 25(3):65-78.
PMID: 38957658 PMC: 11218470. DOI: 10.1007/s11936-023-00977-6.
Galili U, Li J, Schaer G Nanomaterials (Basel). 2024; 14(8).
PMID: 38668224 PMC: 11055133. DOI: 10.3390/nano14080730.
Wilson J, Erickson L, Levin M, Ailsworth S, Commins S, Platts-Mills T Allergy. 2024; 79(6):1440-1454.
PMID: 38193233 PMC: 11142869. DOI: 10.1111/all.16003.
Accelerated Burn Healing in a Mouse Experimental Model Using α-Gal Nanoparticles.
Galili U Bioengineering (Basel). 2023; 10(10).
PMID: 37892895 PMC: 10604883. DOI: 10.3390/bioengineering10101165.